Global Injectable PrEP Market Growth 2026-2032
The global Injectable PrEP market size is predicted to grow from US$ 301 million in 2025 to US$ 831 million in 2032; it is expected to grow at a CAGR of 15.8% from 2026 to 2032.
Injectable PrEP refers to HIV pre-exposure prophylaxis administered via parenteral routes—typically intramuscular or subcutaneous injection—most often in long-acting formulations that create a sustained-release “depot” and maintain protective drug exposure for weeks to months before potential HIV exposure occurs. The core problem it is designed to solve is the real-world implementation gap of oral PrEP: daily or event-driven pill-taking can be difficult to sustain due to adherence burden, refill continuity, privacy constraints, and stigma associated with visible medication use, and missed doses or interruptions can translate into gaps in protection. By shifting prevention from frequent self-managed dosing to periodic clinic- or program-based administration, injectable PrEP aims to improve continuity of coverage, reduce day-to-day behavioral load, and integrate more naturally with testing, follow-up, and broader sexual health services. Historically, injectable PrEP emerged after oral PrEP established efficacy and guidelines, leveraging advances from long-acting HIV treatment technologies—such as micro-/nano-crystal suspensions, stable depot formulations, and aseptic fill-finish—before expanding through regulatory approvals and phased rollout across regions, with service delivery models (visit cadence, workforce training, cold chain, and retention-in-care) becoming a central determinant of real-world uptake. Upstream, injectable PrEP depends on both conventional pharmaceutical inputs and a component-intensive aseptic supply chain: APIs and key intermediates; chemical reagents, solvents, and catalysts; injection-grade excipients (stabilizers, surfactants, buffers, water for injection, and formulation aids as needed); and the packaging/device components required for sterile manufacturing and administration (injectable-grade glass vials or prefilled syringes, elastomer stoppers/plungers, seals, needles and safety injection devices, sterilizing filters, single-use tubing and filling sets, labels, and cold-chain packaging), supported by specialized suppliers providing aseptic fill-finish capacity, sterilization validation, temperature-controlled logistics, and compliant quality systems.In 2025, the global production capacity of injectable PrEP reached 150,000 doses, while total sales amounted to 115,700 doses. The average selling price was USD 2,660 per dose, and manufacturers’ gross margins ranged between 60% and 70%.
United States market for Injectable PrEP is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Injectable PrEP is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Injectable PrEP is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Injectable PrEP players cover Gilead Sciences, ViiV Healthcare, Aurobindo, Cipla, Viatris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Injectable PrEP Industry Forecast” looks at past sales and reviews total world Injectable PrEP sales in 2025, providing a comprehensive analysis by region and market sector of projected Injectable PrEP sales for 2026 through 2032. With Injectable PrEP sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable PrEP industry.
This Insight Report provides a comprehensive analysis of the global Injectable PrEP landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable PrEP portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable PrEP market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable PrEP and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable PrEP.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable PrEP market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Injectable PrEP refers to HIV pre-exposure prophylaxis administered via parenteral routes—typically intramuscular or subcutaneous injection—most often in long-acting formulations that create a sustained-release “depot” and maintain protective drug exposure for weeks to months before potential HIV exposure occurs. The core problem it is designed to solve is the real-world implementation gap of oral PrEP: daily or event-driven pill-taking can be difficult to sustain due to adherence burden, refill continuity, privacy constraints, and stigma associated with visible medication use, and missed doses or interruptions can translate into gaps in protection. By shifting prevention from frequent self-managed dosing to periodic clinic- or program-based administration, injectable PrEP aims to improve continuity of coverage, reduce day-to-day behavioral load, and integrate more naturally with testing, follow-up, and broader sexual health services. Historically, injectable PrEP emerged after oral PrEP established efficacy and guidelines, leveraging advances from long-acting HIV treatment technologies—such as micro-/nano-crystal suspensions, stable depot formulations, and aseptic fill-finish—before expanding through regulatory approvals and phased rollout across regions, with service delivery models (visit cadence, workforce training, cold chain, and retention-in-care) becoming a central determinant of real-world uptake. Upstream, injectable PrEP depends on both conventional pharmaceutical inputs and a component-intensive aseptic supply chain: APIs and key intermediates; chemical reagents, solvents, and catalysts; injection-grade excipients (stabilizers, surfactants, buffers, water for injection, and formulation aids as needed); and the packaging/device components required for sterile manufacturing and administration (injectable-grade glass vials or prefilled syringes, elastomer stoppers/plungers, seals, needles and safety injection devices, sterilizing filters, single-use tubing and filling sets, labels, and cold-chain packaging), supported by specialized suppliers providing aseptic fill-finish capacity, sterilization validation, temperature-controlled logistics, and compliant quality systems.In 2025, the global production capacity of injectable PrEP reached 150,000 doses, while total sales amounted to 115,700 doses. The average selling price was USD 2,660 per dose, and manufacturers’ gross margins ranged between 60% and 70%.
United States market for Injectable PrEP is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Injectable PrEP is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Injectable PrEP is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Injectable PrEP players cover Gilead Sciences, ViiV Healthcare, Aurobindo, Cipla, Viatris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Injectable PrEP Industry Forecast” looks at past sales and reviews total world Injectable PrEP sales in 2025, providing a comprehensive analysis by region and market sector of projected Injectable PrEP sales for 2026 through 2032. With Injectable PrEP sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable PrEP industry.
This Insight Report provides a comprehensive analysis of the global Injectable PrEP landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable PrEP portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable PrEP market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable PrEP and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable PrEP.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable PrEP market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Cabotegravir
- Lenacapavir
- Other
- Short-interval Injections
- Monthly Injections
- Quarterly Injections
- Original Drug
- Generic Drug
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences
- ViiV Healthcare
- Aurobindo
- Cipla
- Viatris
- What is the 10-year outlook for the global Injectable PrEP market?
- What factors are driving Injectable PrEP market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Injectable PrEP market opportunities vary by end market size?
- How does Injectable PrEP break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable PrEP Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Injectable PrEP by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Injectable PrEP by Country/Region, 2021, 2025 & 2032
2.2 Injectable PrEP Segment by Type
2.2.1 Cabotegravir
2.2.2 Lenacapavir
2.2.3 Other
2.2.4 Injectable PrEP Sales by Type
2.2.4.1 Global Injectable PrEP Sales Market Share by Type (2021-2026)
2.2.4.2 Global Injectable PrEP Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Injectable PrEP Sale Price by Type (2021-2026)
2.3 Injectable PrEP Segment by Dosing Interval
2.3.1 Short-interval Injections
2.3.2 Monthly Injections
2.3.3 Quarterly Injections
2.3.4 Injectable PrEP Sales by Dosing Interval
2.3.4.1 Global Injectable PrEP Sales Market Share by Dosing Interval (2021-2026)
2.3.4.2 Global Injectable PrEP Revenue and Market Share by Dosing Interval (2021-2026)
2.3.4.3 Global Injectable PrEP Sale Price by Dosing Interval (2021-2026)
2.4 Injectable PrEP Segment by Drug Properties
2.4.1 Original Drug
2.4.2 Generic Drug
2.4.3 Injectable PrEP Sales by Drug Properties
2.4.3.1 Global Injectable PrEP Sales Market Share by Drug Properties (2021-2026)
2.4.3.2 Global Injectable PrEP Revenue and Market Share by Drug Properties (2021-2026)
2.4.3.3 Global Injectable PrEP Sale Price by Drug Properties (2021-2026)
2.5 Injectable PrEP Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Injectable PrEP Sales by Application
2.5.4.1 Global Injectable PrEP Sale Market Share by Application (2021-2026)
2.5.4.2 Global Injectable PrEP Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Injectable PrEP Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Injectable PrEP Breakdown Data by Company
3.1.1 Global Injectable PrEP Annual Sales by Company (2021-2026)
3.1.2 Global Injectable PrEP Sales Market Share by Company (2021-2026)
3.2 Global Injectable PrEP Annual Revenue by Company (2021-2026)
3.2.1 Global Injectable PrEP Revenue by Company (2021-2026)
3.2.2 Global Injectable PrEP Revenue Market Share by Company (2021-2026)
3.3 Global Injectable PrEP Sale Price by Company
3.4 Key Manufacturers Injectable PrEP Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable PrEP Product Location Distribution
3.4.2 Players Injectable PrEP Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INJECTABLE PREP BY GEOGRAPHIC REGION
4.1 World Historic Injectable PrEP Market Size by Geographic Region (2021-2026)
4.1.1 Global Injectable PrEP Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Injectable PrEP Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Injectable PrEP Market Size by Country/Region (2021-2026)
4.2.1 Global Injectable PrEP Annual Sales by Country/Region (2021-2026)
4.2.2 Global Injectable PrEP Annual Revenue by Country/Region (2021-2026)
4.3 Americas Injectable PrEP Sales Growth
4.4 APAC Injectable PrEP Sales Growth
4.5 Europe Injectable PrEP Sales Growth
4.6 Middle East & Africa Injectable PrEP Sales Growth
5 AMERICAS
5.1 Americas Injectable PrEP Sales by Country
5.1.1 Americas Injectable PrEP Sales by Country (2021-2026)
5.1.2 Americas Injectable PrEP Revenue by Country (2021-2026)
5.2 Americas Injectable PrEP Sales by Type (2021-2026)
5.3 Americas Injectable PrEP Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable PrEP Sales by Region
6.1.1 APAC Injectable PrEP Sales by Region (2021-2026)
6.1.2 APAC Injectable PrEP Revenue by Region (2021-2026)
6.2 APAC Injectable PrEP Sales by Type (2021-2026)
6.3 APAC Injectable PrEP Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable PrEP by Country
7.1.1 Europe Injectable PrEP Sales by Country (2021-2026)
7.1.2 Europe Injectable PrEP Revenue by Country (2021-2026)
7.2 Europe Injectable PrEP Sales by Type (2021-2026)
7.3 Europe Injectable PrEP Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable PrEP by Country
8.1.1 Middle East & Africa Injectable PrEP Sales by Country (2021-2026)
8.1.2 Middle East & Africa Injectable PrEP Revenue by Country (2021-2026)
8.2 Middle East & Africa Injectable PrEP Sales by Type (2021-2026)
8.3 Middle East & Africa Injectable PrEP Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable PrEP
10.3 Manufacturing Process Analysis of Injectable PrEP
10.4 Industry Chain Structure of Injectable PrEP
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable PrEP Distributors
11.3 Injectable PrEP Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE PREP BY GEOGRAPHIC REGION
12.1 Global Injectable PrEP Market Size Forecast by Region
12.1.1 Global Injectable PrEP Forecast by Region (2027-2032)
12.1.2 Global Injectable PrEP Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Injectable PrEP Forecast by Type (2027-2032)
12.7 Global Injectable PrEP Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Injectable PrEP Product Portfolios and Specifications
13.1.3 Gilead Sciences Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 ViiV Healthcare
13.2.1 ViiV Healthcare Company Information
13.2.2 ViiV Healthcare Injectable PrEP Product Portfolios and Specifications
13.2.3 ViiV Healthcare Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 ViiV Healthcare Main Business Overview
13.2.5 ViiV Healthcare Latest Developments
13.3 Aurobindo
13.3.1 Aurobindo Company Information
13.3.2 Aurobindo Injectable PrEP Product Portfolios and Specifications
13.3.3 Aurobindo Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Aurobindo Main Business Overview
13.3.5 Aurobindo Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Injectable PrEP Product Portfolios and Specifications
13.4.3 Cipla Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Injectable PrEP Product Portfolios and Specifications
13.5.3 Viatris Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable PrEP Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Injectable PrEP by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Injectable PrEP by Country/Region, 2021, 2025 & 2032
2.2 Injectable PrEP Segment by Type
2.2.1 Cabotegravir
2.2.2 Lenacapavir
2.2.3 Other
2.2.4 Injectable PrEP Sales by Type
2.2.4.1 Global Injectable PrEP Sales Market Share by Type (2021-2026)
2.2.4.2 Global Injectable PrEP Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Injectable PrEP Sale Price by Type (2021-2026)
2.3 Injectable PrEP Segment by Dosing Interval
2.3.1 Short-interval Injections
2.3.2 Monthly Injections
2.3.3 Quarterly Injections
2.3.4 Injectable PrEP Sales by Dosing Interval
2.3.4.1 Global Injectable PrEP Sales Market Share by Dosing Interval (2021-2026)
2.3.4.2 Global Injectable PrEP Revenue and Market Share by Dosing Interval (2021-2026)
2.3.4.3 Global Injectable PrEP Sale Price by Dosing Interval (2021-2026)
2.4 Injectable PrEP Segment by Drug Properties
2.4.1 Original Drug
2.4.2 Generic Drug
2.4.3 Injectable PrEP Sales by Drug Properties
2.4.3.1 Global Injectable PrEP Sales Market Share by Drug Properties (2021-2026)
2.4.3.2 Global Injectable PrEP Revenue and Market Share by Drug Properties (2021-2026)
2.4.3.3 Global Injectable PrEP Sale Price by Drug Properties (2021-2026)
2.5 Injectable PrEP Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Injectable PrEP Sales by Application
2.5.4.1 Global Injectable PrEP Sale Market Share by Application (2021-2026)
2.5.4.2 Global Injectable PrEP Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Injectable PrEP Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Injectable PrEP Breakdown Data by Company
3.1.1 Global Injectable PrEP Annual Sales by Company (2021-2026)
3.1.2 Global Injectable PrEP Sales Market Share by Company (2021-2026)
3.2 Global Injectable PrEP Annual Revenue by Company (2021-2026)
3.2.1 Global Injectable PrEP Revenue by Company (2021-2026)
3.2.2 Global Injectable PrEP Revenue Market Share by Company (2021-2026)
3.3 Global Injectable PrEP Sale Price by Company
3.4 Key Manufacturers Injectable PrEP Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable PrEP Product Location Distribution
3.4.2 Players Injectable PrEP Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INJECTABLE PREP BY GEOGRAPHIC REGION
4.1 World Historic Injectable PrEP Market Size by Geographic Region (2021-2026)
4.1.1 Global Injectable PrEP Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Injectable PrEP Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Injectable PrEP Market Size by Country/Region (2021-2026)
4.2.1 Global Injectable PrEP Annual Sales by Country/Region (2021-2026)
4.2.2 Global Injectable PrEP Annual Revenue by Country/Region (2021-2026)
4.3 Americas Injectable PrEP Sales Growth
4.4 APAC Injectable PrEP Sales Growth
4.5 Europe Injectable PrEP Sales Growth
4.6 Middle East & Africa Injectable PrEP Sales Growth
5 AMERICAS
5.1 Americas Injectable PrEP Sales by Country
5.1.1 Americas Injectable PrEP Sales by Country (2021-2026)
5.1.2 Americas Injectable PrEP Revenue by Country (2021-2026)
5.2 Americas Injectable PrEP Sales by Type (2021-2026)
5.3 Americas Injectable PrEP Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable PrEP Sales by Region
6.1.1 APAC Injectable PrEP Sales by Region (2021-2026)
6.1.2 APAC Injectable PrEP Revenue by Region (2021-2026)
6.2 APAC Injectable PrEP Sales by Type (2021-2026)
6.3 APAC Injectable PrEP Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable PrEP by Country
7.1.1 Europe Injectable PrEP Sales by Country (2021-2026)
7.1.2 Europe Injectable PrEP Revenue by Country (2021-2026)
7.2 Europe Injectable PrEP Sales by Type (2021-2026)
7.3 Europe Injectable PrEP Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable PrEP by Country
8.1.1 Middle East & Africa Injectable PrEP Sales by Country (2021-2026)
8.1.2 Middle East & Africa Injectable PrEP Revenue by Country (2021-2026)
8.2 Middle East & Africa Injectable PrEP Sales by Type (2021-2026)
8.3 Middle East & Africa Injectable PrEP Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable PrEP
10.3 Manufacturing Process Analysis of Injectable PrEP
10.4 Industry Chain Structure of Injectable PrEP
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable PrEP Distributors
11.3 Injectable PrEP Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE PREP BY GEOGRAPHIC REGION
12.1 Global Injectable PrEP Market Size Forecast by Region
12.1.1 Global Injectable PrEP Forecast by Region (2027-2032)
12.1.2 Global Injectable PrEP Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Injectable PrEP Forecast by Type (2027-2032)
12.7 Global Injectable PrEP Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Injectable PrEP Product Portfolios and Specifications
13.1.3 Gilead Sciences Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 ViiV Healthcare
13.2.1 ViiV Healthcare Company Information
13.2.2 ViiV Healthcare Injectable PrEP Product Portfolios and Specifications
13.2.3 ViiV Healthcare Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 ViiV Healthcare Main Business Overview
13.2.5 ViiV Healthcare Latest Developments
13.3 Aurobindo
13.3.1 Aurobindo Company Information
13.3.2 Aurobindo Injectable PrEP Product Portfolios and Specifications
13.3.3 Aurobindo Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Aurobindo Main Business Overview
13.3.5 Aurobindo Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Injectable PrEP Product Portfolios and Specifications
13.4.3 Cipla Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Injectable PrEP Product Portfolios and Specifications
13.5.3 Viatris Injectable PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Injectable PrEP Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Injectable PrEP Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cabotegravir
Table 4. Major Players of Lenacapavir
Table 5. Major Players of Other
Table 6. Global Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 7. Global Injectable PrEP Sales Market Share by Type (2021-2026)
Table 8. Global Injectable PrEP Revenue by Type (2021-2026) & ($ million)
Table 9. Global Injectable PrEP Revenue Market Share by Type (2021-2026)
Table 10. Global Injectable PrEP Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Short-interval Injections
Table 12. Major Players of Monthly Injections
Table 13. Major Players of Quarterly Injections
Table 14. Global Injectable PrEP Sales by Dosing Interval (2021-2026) & (K Dose)
Table 15. Global Injectable PrEP Sales Market Share by Dosing Interval (2021-2026)
Table 16. Global Injectable PrEP Revenue by Dosing Interval (2021-2026) & ($ million)
Table 17. Global Injectable PrEP Revenue Market Share by Dosing Interval (2021-2026)
Table 18. Global Injectable PrEP Sale Price by Dosing Interval (2021-2026) & (US$/Dose)
Table 19. Major Players of Original Drug
Table 20. Major Players of Generic Drug
Table 21. Global Injectable PrEP Sales by Drug Properties (2021-2026) & (K Dose)
Table 22. Global Injectable PrEP Sales Market Share by Drug Properties (2021-2026)
Table 23. Global Injectable PrEP Revenue by Drug Properties (2021-2026) & ($ million)
Table 24. Global Injectable PrEP Revenue Market Share by Drug Properties (2021-2026)
Table 25. Global Injectable PrEP Sale Price by Drug Properties (2021-2026) & (US$/Dose)
Table 26. Global Injectable PrEP Sale by Application (2021-2026) & (K Dose)
Table 27. Global Injectable PrEP Sale Market Share by Application (2021-2026)
Table 28. Global Injectable PrEP Revenue by Application (2021-2026) & ($ million)
Table 29. Global Injectable PrEP Revenue Market Share by Application (2021-2026)
Table 30. Global Injectable PrEP Sale Price by Application (2021-2026) & (US$/Dose)
Table 31. Global Injectable PrEP Sales by Company (2021-2026) & (K Dose)
Table 32. Global Injectable PrEP Sales Market Share by Company (2021-2026)
Table 33. Global Injectable PrEP Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Injectable PrEP Revenue Market Share by Company (2021-2026)
Table 35. Global Injectable PrEP Sale Price by Company (2021-2026) & (US$/Dose)
Table 36. Key Manufacturers Injectable PrEP Producing Area Distribution and Sales Area
Table 37. Players Injectable PrEP Products Offered
Table 38. Injectable PrEP Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Injectable PrEP Sales by Geographic Region (2021-2026) & (K Dose)
Table 42. Global Injectable PrEP Sales Market Share Geographic Region (2021-2026)
Table 43. Global Injectable PrEP Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Injectable PrEP Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Injectable PrEP Sales by Country/Region (2021-2026) & (K Dose)
Table 46. Global Injectable PrEP Sales Market Share by Country/Region (2021-2026)
Table 47. Global Injectable PrEP Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Injectable PrEP Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Injectable PrEP Sales by Country (2021-2026) & (K Dose)
Table 50. Americas Injectable PrEP Sales Market Share by Country (2021-2026)
Table 51. Americas Injectable PrEP Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 53. Americas Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 54. APAC Injectable PrEP Sales by Region (2021-2026) & (K Dose)
Table 55. APAC Injectable PrEP Sales Market Share by Region (2021-2026)
Table 56. APAC Injectable PrEP Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 58. APAC Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 59. Europe Injectable PrEP Sales by Country (2021-2026) & (K Dose)
Table 60. Europe Injectable PrEP Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 62. Europe Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 63. Middle East & Africa Injectable PrEP Sales by Country (2021-2026) & (K Dose)
Table 64. Middle East & Africa Injectable PrEP Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 66. Middle East & Africa Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 67. Key Market Drivers & Growth Opportunities of Injectable PrEP
Table 68. Key Market Challenges & Risks of Injectable PrEP
Table 69. Key Industry Trends of Injectable PrEP
Table 70. Injectable PrEP Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Injectable PrEP Distributors List
Table 73. Injectable PrEP Customer List
Table 74. Global Injectable PrEP Sales Forecast by Region (2027-2032) & (K Dose)
Table 75. Global Injectable PrEP Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Injectable PrEP Sales Forecast by Country (2027-2032) & (K Dose)
Table 77. Americas Injectable PrEP Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Injectable PrEP Sales Forecast by Region (2027-2032) & (K Dose)
Table 79. APAC Injectable PrEP Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Injectable PrEP Sales Forecast by Country (2027-2032) & (K Dose)
Table 81. Europe Injectable PrEP Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Injectable PrEP Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Middle East & Africa Injectable PrEP Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Injectable PrEP Sales Forecast by Type (2027-2032) & (K Dose)
Table 85. Global Injectable PrEP Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Injectable PrEP Sales Forecast by Application (2027-2032) & (K Dose)
Table 87. Global Injectable PrEP Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Gilead Sciences Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 89. Gilead Sciences Injectable PrEP Product Portfolios and Specifications
Table 90. Gilead Sciences Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Gilead Sciences Main Business
Table 92. Gilead Sciences Latest Developments
Table 93. ViiV Healthcare Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 94. ViiV Healthcare Injectable PrEP Product Portfolios and Specifications
Table 95. ViiV Healthcare Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. ViiV Healthcare Main Business
Table 97. ViiV Healthcare Latest Developments
Table 98. Aurobindo Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 99. Aurobindo Injectable PrEP Product Portfolios and Specifications
Table 100. Aurobindo Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. Aurobindo Main Business
Table 102. Aurobindo Latest Developments
Table 103. Cipla Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 104. Cipla Injectable PrEP Product Portfolios and Specifications
Table 105. Cipla Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 106. Cipla Main Business
Table 107. Cipla Latest Developments
Table 108. Viatris Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 109. Viatris Injectable PrEP Product Portfolios and Specifications
Table 110. Viatris Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 111. Viatris Main Business
Table 112. Viatris Latest Developments
Table 1. Injectable PrEP Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Injectable PrEP Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cabotegravir
Table 4. Major Players of Lenacapavir
Table 5. Major Players of Other
Table 6. Global Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 7. Global Injectable PrEP Sales Market Share by Type (2021-2026)
Table 8. Global Injectable PrEP Revenue by Type (2021-2026) & ($ million)
Table 9. Global Injectable PrEP Revenue Market Share by Type (2021-2026)
Table 10. Global Injectable PrEP Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Short-interval Injections
Table 12. Major Players of Monthly Injections
Table 13. Major Players of Quarterly Injections
Table 14. Global Injectable PrEP Sales by Dosing Interval (2021-2026) & (K Dose)
Table 15. Global Injectable PrEP Sales Market Share by Dosing Interval (2021-2026)
Table 16. Global Injectable PrEP Revenue by Dosing Interval (2021-2026) & ($ million)
Table 17. Global Injectable PrEP Revenue Market Share by Dosing Interval (2021-2026)
Table 18. Global Injectable PrEP Sale Price by Dosing Interval (2021-2026) & (US$/Dose)
Table 19. Major Players of Original Drug
Table 20. Major Players of Generic Drug
Table 21. Global Injectable PrEP Sales by Drug Properties (2021-2026) & (K Dose)
Table 22. Global Injectable PrEP Sales Market Share by Drug Properties (2021-2026)
Table 23. Global Injectable PrEP Revenue by Drug Properties (2021-2026) & ($ million)
Table 24. Global Injectable PrEP Revenue Market Share by Drug Properties (2021-2026)
Table 25. Global Injectable PrEP Sale Price by Drug Properties (2021-2026) & (US$/Dose)
Table 26. Global Injectable PrEP Sale by Application (2021-2026) & (K Dose)
Table 27. Global Injectable PrEP Sale Market Share by Application (2021-2026)
Table 28. Global Injectable PrEP Revenue by Application (2021-2026) & ($ million)
Table 29. Global Injectable PrEP Revenue Market Share by Application (2021-2026)
Table 30. Global Injectable PrEP Sale Price by Application (2021-2026) & (US$/Dose)
Table 31. Global Injectable PrEP Sales by Company (2021-2026) & (K Dose)
Table 32. Global Injectable PrEP Sales Market Share by Company (2021-2026)
Table 33. Global Injectable PrEP Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Injectable PrEP Revenue Market Share by Company (2021-2026)
Table 35. Global Injectable PrEP Sale Price by Company (2021-2026) & (US$/Dose)
Table 36. Key Manufacturers Injectable PrEP Producing Area Distribution and Sales Area
Table 37. Players Injectable PrEP Products Offered
Table 38. Injectable PrEP Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Injectable PrEP Sales by Geographic Region (2021-2026) & (K Dose)
Table 42. Global Injectable PrEP Sales Market Share Geographic Region (2021-2026)
Table 43. Global Injectable PrEP Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Injectable PrEP Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Injectable PrEP Sales by Country/Region (2021-2026) & (K Dose)
Table 46. Global Injectable PrEP Sales Market Share by Country/Region (2021-2026)
Table 47. Global Injectable PrEP Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Injectable PrEP Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Injectable PrEP Sales by Country (2021-2026) & (K Dose)
Table 50. Americas Injectable PrEP Sales Market Share by Country (2021-2026)
Table 51. Americas Injectable PrEP Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 53. Americas Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 54. APAC Injectable PrEP Sales by Region (2021-2026) & (K Dose)
Table 55. APAC Injectable PrEP Sales Market Share by Region (2021-2026)
Table 56. APAC Injectable PrEP Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 58. APAC Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 59. Europe Injectable PrEP Sales by Country (2021-2026) & (K Dose)
Table 60. Europe Injectable PrEP Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 62. Europe Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 63. Middle East & Africa Injectable PrEP Sales by Country (2021-2026) & (K Dose)
Table 64. Middle East & Africa Injectable PrEP Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Injectable PrEP Sales by Type (2021-2026) & (K Dose)
Table 66. Middle East & Africa Injectable PrEP Sales by Application (2021-2026) & (K Dose)
Table 67. Key Market Drivers & Growth Opportunities of Injectable PrEP
Table 68. Key Market Challenges & Risks of Injectable PrEP
Table 69. Key Industry Trends of Injectable PrEP
Table 70. Injectable PrEP Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Injectable PrEP Distributors List
Table 73. Injectable PrEP Customer List
Table 74. Global Injectable PrEP Sales Forecast by Region (2027-2032) & (K Dose)
Table 75. Global Injectable PrEP Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Injectable PrEP Sales Forecast by Country (2027-2032) & (K Dose)
Table 77. Americas Injectable PrEP Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Injectable PrEP Sales Forecast by Region (2027-2032) & (K Dose)
Table 79. APAC Injectable PrEP Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Injectable PrEP Sales Forecast by Country (2027-2032) & (K Dose)
Table 81. Europe Injectable PrEP Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Injectable PrEP Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Middle East & Africa Injectable PrEP Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Injectable PrEP Sales Forecast by Type (2027-2032) & (K Dose)
Table 85. Global Injectable PrEP Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Injectable PrEP Sales Forecast by Application (2027-2032) & (K Dose)
Table 87. Global Injectable PrEP Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Gilead Sciences Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 89. Gilead Sciences Injectable PrEP Product Portfolios and Specifications
Table 90. Gilead Sciences Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Gilead Sciences Main Business
Table 92. Gilead Sciences Latest Developments
Table 93. ViiV Healthcare Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 94. ViiV Healthcare Injectable PrEP Product Portfolios and Specifications
Table 95. ViiV Healthcare Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. ViiV Healthcare Main Business
Table 97. ViiV Healthcare Latest Developments
Table 98. Aurobindo Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 99. Aurobindo Injectable PrEP Product Portfolios and Specifications
Table 100. Aurobindo Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. Aurobindo Main Business
Table 102. Aurobindo Latest Developments
Table 103. Cipla Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 104. Cipla Injectable PrEP Product Portfolios and Specifications
Table 105. Cipla Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 106. Cipla Main Business
Table 107. Cipla Latest Developments
Table 108. Viatris Basic Information, Injectable PrEP Manufacturing Base, Sales Area and Its Competitors
Table 109. Viatris Injectable PrEP Product Portfolios and Specifications
Table 110. Viatris Injectable PrEP Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 111. Viatris Main Business
Table 112. Viatris Latest Developments
LIST OF FIGURES
Figure 1. Picture of Injectable PrEP
Figure 2. Injectable PrEP Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable PrEP Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Injectable PrEP Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Injectable PrEP Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Injectable PrEP Sales Market Share by Country/Region (2025)
Figure 10. Injectable PrEP Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cabotegravir
Figure 12. Product Picture of Lenacapavir
Figure 13. Product Picture of Other
Figure 14. Global Injectable PrEP Sales Market Share by Type in 2026
Figure 15. Global Injectable PrEP Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Short-interval Injections
Figure 17. Product Picture of Monthly Injections
Figure 18. Product Picture of Quarterly Injections
Figure 19. Global Injectable PrEP Sales Market Share by Dosing Interval in 2026
Figure 20. Global Injectable PrEP Revenue Market Share by Dosing Interval (2021-2026)
Figure 21. Product Picture of Original Drug
Figure 22. Product Picture of Generic Drug
Figure 23. Global Injectable PrEP Sales Market Share by Drug Properties in 2026
Figure 24. Global Injectable PrEP Revenue Market Share by Drug Properties (2021-2026)
Figure 25. Injectable PrEP Consumed in Hospital
Figure 26. Global Injectable PrEP Market: Hospital (2021-2026) & (K Dose)
Figure 27. Injectable PrEP Consumed in Clinic
Figure 28. Global Injectable PrEP Market: Clinic (2021-2026) & (K Dose)
Figure 29. Injectable PrEP Consumed in Other
Figure 30. Global Injectable PrEP Market: Other (2021-2026) & (K Dose)
Figure 31. Global Injectable PrEP Sale Market Share by Application (2025)
Figure 32. Global Injectable PrEP Revenue Market Share by Application in 2026
Figure 33. Injectable PrEP Sales by Company in 2026 (K Dose)
Figure 34. Global Injectable PrEP Sales Market Share by Company in 2026
Figure 35. Injectable PrEP Revenue by Company in 2026 ($ millions)
Figure 36. Global Injectable PrEP Revenue Market Share by Company in 2026
Figure 37. Global Injectable PrEP Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Injectable PrEP Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Injectable PrEP Sales 2021-2026 (K Dose)
Figure 40. Americas Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 41. APAC Injectable PrEP Sales 2021-2026 (K Dose)
Figure 42. APAC Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 43. Europe Injectable PrEP Sales 2021-2026 (K Dose)
Figure 44. Europe Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Injectable PrEP Sales 2021-2026 (K Dose)
Figure 46. Middle East & Africa Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 47. Americas Injectable PrEP Sales Market Share by Country in 2026
Figure 48. Americas Injectable PrEP Revenue Market Share by Country (2021-2026)
Figure 49. Americas Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 50. Americas Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 51. United States Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Injectable PrEP Sales Market Share by Region in 2026
Figure 56. APAC Injectable PrEP Revenue Market Share by Region (2021-2026)
Figure 57. APAC Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 58. APAC Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 59. China Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 63. India Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Injectable PrEP Sales Market Share by Country in 2026
Figure 67. Europe Injectable PrEP Revenue Market Share by Country (2021-2026)
Figure 68. Europe Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 69. Europe Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 70. Germany Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 71. France Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Injectable PrEP Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 78. Egypt Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Injectable PrEP in 2026
Figure 84. Manufacturing Process Analysis of Injectable PrEP
Figure 85. Industry Chain Structure of Injectable PrEP
Figure 86. Channels of Distribution
Figure 87. Global Injectable PrEP Sales Market Forecast by Region (2027-2032)
Figure 88. Global Injectable PrEP Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Injectable PrEP Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Injectable PrEP Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Injectable PrEP Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Injectable PrEP Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Injectable PrEP
Figure 2. Injectable PrEP Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable PrEP Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Injectable PrEP Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Injectable PrEP Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Injectable PrEP Sales Market Share by Country/Region (2025)
Figure 10. Injectable PrEP Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cabotegravir
Figure 12. Product Picture of Lenacapavir
Figure 13. Product Picture of Other
Figure 14. Global Injectable PrEP Sales Market Share by Type in 2026
Figure 15. Global Injectable PrEP Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Short-interval Injections
Figure 17. Product Picture of Monthly Injections
Figure 18. Product Picture of Quarterly Injections
Figure 19. Global Injectable PrEP Sales Market Share by Dosing Interval in 2026
Figure 20. Global Injectable PrEP Revenue Market Share by Dosing Interval (2021-2026)
Figure 21. Product Picture of Original Drug
Figure 22. Product Picture of Generic Drug
Figure 23. Global Injectable PrEP Sales Market Share by Drug Properties in 2026
Figure 24. Global Injectable PrEP Revenue Market Share by Drug Properties (2021-2026)
Figure 25. Injectable PrEP Consumed in Hospital
Figure 26. Global Injectable PrEP Market: Hospital (2021-2026) & (K Dose)
Figure 27. Injectable PrEP Consumed in Clinic
Figure 28. Global Injectable PrEP Market: Clinic (2021-2026) & (K Dose)
Figure 29. Injectable PrEP Consumed in Other
Figure 30. Global Injectable PrEP Market: Other (2021-2026) & (K Dose)
Figure 31. Global Injectable PrEP Sale Market Share by Application (2025)
Figure 32. Global Injectable PrEP Revenue Market Share by Application in 2026
Figure 33. Injectable PrEP Sales by Company in 2026 (K Dose)
Figure 34. Global Injectable PrEP Sales Market Share by Company in 2026
Figure 35. Injectable PrEP Revenue by Company in 2026 ($ millions)
Figure 36. Global Injectable PrEP Revenue Market Share by Company in 2026
Figure 37. Global Injectable PrEP Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Injectable PrEP Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Injectable PrEP Sales 2021-2026 (K Dose)
Figure 40. Americas Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 41. APAC Injectable PrEP Sales 2021-2026 (K Dose)
Figure 42. APAC Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 43. Europe Injectable PrEP Sales 2021-2026 (K Dose)
Figure 44. Europe Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Injectable PrEP Sales 2021-2026 (K Dose)
Figure 46. Middle East & Africa Injectable PrEP Revenue 2021-2026 ($ millions)
Figure 47. Americas Injectable PrEP Sales Market Share by Country in 2026
Figure 48. Americas Injectable PrEP Revenue Market Share by Country (2021-2026)
Figure 49. Americas Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 50. Americas Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 51. United States Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Injectable PrEP Sales Market Share by Region in 2026
Figure 56. APAC Injectable PrEP Revenue Market Share by Region (2021-2026)
Figure 57. APAC Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 58. APAC Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 59. China Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 63. India Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Injectable PrEP Sales Market Share by Country in 2026
Figure 67. Europe Injectable PrEP Revenue Market Share by Country (2021-2026)
Figure 68. Europe Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 69. Europe Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 70. Germany Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 71. France Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Injectable PrEP Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Injectable PrEP Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Injectable PrEP Sales Market Share by Application (2021-2026)
Figure 78. Egypt Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Injectable PrEP Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Injectable PrEP in 2026
Figure 84. Manufacturing Process Analysis of Injectable PrEP
Figure 85. Industry Chain Structure of Injectable PrEP
Figure 86. Channels of Distribution
Figure 87. Global Injectable PrEP Sales Market Forecast by Region (2027-2032)
Figure 88. Global Injectable PrEP Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Injectable PrEP Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Injectable PrEP Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Injectable PrEP Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Injectable PrEP Revenue Market Share Forecast by Application (2027-2032)
